19-yr-old girl hacked to death by father over inter-caste love in Karnataka

Journalist Mohammad Hijazi has been killed in an Israeli attack, raising the number of media workers killed by Zionist forces since the start of the war on Gaza to 220.

The Israeli regime forces killed the Palestinian writer, poet and journalist in an airstrike on northern Gaza’s Jabalia refugee camp, according to his family.

He was among nearly 90 other Palestinians killed in Israeli bombardment across the besieged territory in the last 24 hours, according to a Gaza Health Ministry statement on Sunday.

“I don’t know if I will write to you again. I keep what I have written and am writing. Maybe it will come to light one day. I refuse a cheap death. I curse the murderer,” Hijazi wrote in a post on social media in August 2023.

“Let us in this bottom that we have finally reached, arm ourselves with patience and prayer, and count the days we have lived as a historic achievement while awaiting what is coming with a broken heart, an extinguished eye, a head held high, and a spirit that fights until the end of the road.”

Since the Israeli killing machine imposed a military siege of northern Gaza in early October intensifying its bombing attacks on the the Jabalia camp, hundreds of people have been killed.

Gaza’s Health Ministry reported on Sunday that at least 88 Palestinians had been killed and 208 others injured in the past 24 hours alone.

According to media reports from central Gaza, among those killed in the latest Israeli strikes across Gaza on Sunday were three Palestinians who were living in a tent in Deir el-Balah.

A family of 15 people was also buried under the rubble in Gaza City, following a separate strike, media reported.

The Israeli regime launched its genocidal war on the Gaza Strip following a surprise operation by the Palestinian  Hamas resistance movement in October last year, killing more than 45,805 Palestinians and wounding 109,064 others.

Mangaluru: In a significant development, Mescom has proposed a phased electricity tariff hike starting with Rs 0.70 per unit for the fiscal year 2025-26. The proposal has been submitted to the Karnataka Electricity Regulatory Commission (KERC) for approval, signaling a potential increase in electricity costs for consumers.

Mescom emphasized that the current tariff structure is insufficient to meet operational expenses and manage revenue effectively. To address this, the company has invited public objections to the proposed hike.

Currently, the electricity supply cost is Rs 9.23 per unit, while the consumer tariff stands at Rs 8.53 per unit, leading to a shortfall of Rs 0.70 per unit. For the financial year 2023-24, Mescom reported revenue of Rs 5,924.73 crore against an expenditure of Rs 6,310.39 crore, resulting in a deficit of Rs 367.66 crore. For the 2025-26 fiscal year, projected revenue is Rs 5,850.81 crore, with an actual requirement of Rs 5,961.63 crore, creating a deficit of Rs 110.82 crore.

In a first, Mescom has submitted a multi-year tariff revision proposal to KERC. The plan outlines a hike of Rs 0.70 per unit for 2025-26, followed by Rs 0.37 per unit for 2026-27 and Rs 0.54 per unit for 2027-28.

"An increase in electricity tariff is inevitable," stated Jayakumar R, Managing Director of Mescom. "Mescom has submitted a proposal in this regard to KERC."

Two cases of Human Metapneumovirus (HMPV) were reported in Bengaluru on January 6 - a 3-month-old baby who has been discharged and an 8-month-old who is recovering at a hospital in the Karnataka capital. This marks the first reported cases of HMPV in India.

The infected infants and their families have no recent travel history, ruling out exposure from other regions or countries, the health department said.

HMPV is a respiratory virus that often causes mild symptoms resembling a cold but can lead to other complications, particularly in infants, the elderly, and those with weakened immune systems. The virus can occasionally trigger pneumonia or exacerbate chronic respiratory conditions. Cases typically rise during the winter and early spring.

The Centre announced on Sunday that it is monitoring HMPV and other respiratory viruses, especially following recent reports of increased respiratory illnesses in China. A Joint Monitoring Group (JMG) convened on January 4 to evaluate the situation, with representatives from the World Health Organisation (WHO), National Centre for Disease Control (NCDC), Indian Council of Medical Research (ICMR), and other health organisations participating.

Respiratory illnesses in China align with seasonal variations caused by viruses such as influenza, RSV, and HMPV. Current surveillance data from India does not indicate any unusual surge in respiratory infections, according to the Ministry of Health and Family Welfare.

As a precaution, the Centre has increased laboratory capacity for HMPV testing. The ICMR will monitor HMPV trends throughout the year, alongside other respiratory illnesses such as influenza-like illness (ILI) and severe acute respiratory infections (SARI). A robust network of surveillance systems, including those operated by ICMR and the Integrated Disease Surveillance Programme (IDSP), continues to track respiratory infections across the country.

Hospitals have been advised to strengthen isolation protocols for suspected cases, ensure the availability of essential medicines, and promptly report ILI and SARI cases through the Integrated Health Information Platform (IHIP).

Precautions to Take:

To reduce the risk of HMPV infection, individuals are advised to:

• Wash hands frequently with soap and water for at least 20 seconds.
• Avoid close contact with people who have respiratory symptoms.
• Wear masks in crowded or high-risk areas, especially during seasonal outbreaks.
• Maintain good indoor ventilation by keeping windows open when possible.
• Disinfect commonly touched surfaces regularly, such as doorknobs, toys, and tables.
• Monitor infants, the elderly, and people with chronic illnesses for symptoms like persistent cough or breathing difficulties.
• Seek prompt medical attention if respiratory symptoms worsen or persist.